The Tobacco and Vaping Products Act is Canada’s federal law regulating the manufacture, sale, labelling, and promotion of tobacco and vaping products sold in Canada. Health Canada states that the TVPA is part of Canada’s strategy to protect Canadians from tobacco-related death and disease.

The third legislative review of the TVPA was Health Canada’s 2026 review focused on compliance and enforcement of the Act. Health Canada tabled the report in Parliament on May 20, 2026.

Yes. The final report lists 43 submissions under “Letter-writing campaign,” with a footnote stating that these submissions used templated wording related to the regulation of cigars.

The report states that the letter-writing campaign recommended differentiating the regulatory approach for cigars, including exempting cigars from certain regulatory requirements for tobacco products.

No. The cigar recommendation was acknowledged under “Other feedback received,” and the report states that these suggestions will continue to be assessed and considered, where appropriate

Bill C-31 proposes changing the TVPA review cycle from every two years to every five years. If enacted, this would make timely follow-up on unresolved category issues, including premium cigar regulation, even more important.

No. CAC supports responsible regulation, youth protection, compliance, and evidence-based policy. The issue is not whether premium cigars should be regulated. The issue is whether they should be regulated distinctly, proportionately, and intelligently.